Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo de estudio
País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Transplantation ; 101(3): e68-e74, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28222055

RESUMEN

BACKGROUND: Vascularized composite allografts, particularly hand and forearm, have limited ischemic tolerance after procurement. In bilateral hand transplantations, this demands a 2 team approach and expedited transfer of the allograft, limiting the recovery to a small geographic area. Ex situ perfusion may be an alternative allograft preservation method to extend allograft survival time. This is a short report of 5 human limbs maintained for 24 hours with ex situ perfusion. METHODS: Upper limbs were procured from brain-dead organ donors. Following recovery, the brachial artery was cannulated and flushed with 10 000 U of heparin. The limb was then attached to a custom-made, near-normothermic (30-33°C) ex situ perfusion system composed of a pump, reservoir, and oxygenator. Perfusate was plasma-based with a hemoglobin concentration of 4 to 6 g/dL. RESULTS: Average warm ischemia time was 76 minutes. Perfusion was maintained at an average systolic pressure of 93 ± 2 mm Hg, flow 310 ± 20 mL/min, and vascular resistance 153 ± 16 mm Hg/L per minute. Average oxygen consumption was 1.1 ± 0.2 mL/kg per minute. Neuromuscular electrical stimulation continually displayed contraction until the end of perfusion, and histology showed no myocyte injury. CONCLUSIONS: Human limb allografts appeared viable after 24 hours of near-normothermic ex situ perfusion. Although these results are early and need validation with transplantation, this technology has promise for extending allograft storage times.


Asunto(s)
Aloinjertos Compuestos/irrigación sanguínea , Aloinjertos Compuestos/trasplante , Preservación de Órganos/métodos , Perfusión/métodos , Extremidad Superior/irrigación sanguínea , Extremidad Superior/cirugía , Alotrasplante Compuesto Vascularizado/métodos , Adulto , Anciano , Biomarcadores/sangre , Muerte Encefálica , Aloinjertos Compuestos/inervación , Estimulación Eléctrica , Diseño de Equipo , Femenino , Hemodinámica , Humanos , Masculino , Persona de Mediana Edad , Contracción Muscular , Preservación de Órganos/efectos adversos , Preservación de Órganos/instrumentación , Consumo de Oxígeno , Perfusión/efectos adversos , Perfusión/instrumentación , Daño por Reperfusión/etiología , Daño por Reperfusión/prevención & control , Factores de Tiempo , Donantes de Tejidos , Supervivencia Tisular , Extremidad Superior/inervación , Alotrasplante Compuesto Vascularizado/efectos adversos , Isquemia Tibia
3.
Am J Transplant ; 5(4 Pt 2): 958-66, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15760421

RESUMEN

Previous measures of OPO performance based on population counts have been deemed inadequate, and the need for new methods has been widely accepted. This article explains recent developments in OPO performance evaluation methodology, including those developed by the SRTR. As a replacement for the previously established measure of OPO performance--donors per million population--using eligible deaths as a national metric has yielded promising results for understanding variations in donation rates among the donation service areas assigned to each OPO. A major improvement uses "notifiable deaths" as a denominator describing a standardized maximal pool of potential donors. Notifiable deaths are defined as in-hospital deaths among ages 70 years and under, excluding certain diagnosis codes related to infections, cancers, etc. A most proximal denominator for determining donation rates is "eligible deaths," which includes only those deaths meeting the criteria for organ donation upon initial assessment. Neither measure is based on the population of a geographic unit, but on restricted upper limits of deaths that could be potential donors in any one locale (e.g., hospital or OPO). The inherent strengths and weaknesses of metrics such as donors per eligible deaths, donors per notifiable deaths, and number of organs per donor are discussed in detail.


Asunto(s)
Donantes de Tejidos/provisión & distribución , Obtención de Tejidos y Órganos/estadística & datos numéricos , Trasplante/estadística & datos numéricos , Humanos , Obtención de Tejidos y Órganos/organización & administración
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA